Related Experiment Videos
[Sotalol--atrial fibrillation, reduced renal function and sudden death]
Summary
Sotalol overdose in kidney failure can cause fatal heart arrhythmias like torsade de pointes. This case highlights the critical need to adjust sotalol dosage in patients with renal impairment to prevent adverse drug events.
Area of Science:
- Cardiology
- Pharmacology
- Nephrology
Background:
- Sotalol, a beta-blocker with antiarrhythmic properties, is used for various cardiac conditions.
- Its pharmacokinetics can lead to elevated serum levels in patients with impaired kidney function.
Observation:
- A patient with paroxysmal atrial fibrillation and kidney failure experienced torsade de pointes ventricular tachycardia while on sotalol.
- Progressive QT interval prolongation indicated a potential sotalol overdose.
Findings:
- The patient's kidney failure led to increased sotalol serum levels, triggering a fatal cardiac event.
- The case demonstrates a link between renal impairment, sotalol accumulation, and life-threatening arrhythmias.
Implications:
- This case underscores the importance of careful sotalol dosage adjustment in patients with reduced kidney function.
- Recent studies, like the SWORD trial, have narrowed the indications for sotalol, emphasizing its use in severe arrhythmias only.